News
MorphoSys Launches New Antibody Technology
MorphoSys AG has launched a novel antibody optimization platform called arYla. The company plans to use arYla to accelerate antibody optimization, with the goal...
News
Biomoda Selects Quintiles To Refine Lung Cancer Tests
Biomoda, Inc. has allied with Quintiles Global Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and...
News
Boehringer Ingelheim entered into a collabration agreement with VTU Technology
Boehringer Ingelheim, a global leader in biopharmaceutical contract development and manufacture, and VTU Technology, a leading supplier of exclusive technologies and comprehensive services for...
Clinical Trials
Novartis discontinues ASA404 clinical trial program and shifts focus to other cancer compounds in early and late stage development
Novartis announced that the clinical trial program for the investigational cancer treatment ASA404 (vadimezan) will be discontinued and resources will be reallocated to other...
Press Releases
Forest Laboratories Enters Collaboration on Bystolic(R) and Savella(R)
Forest Laboratories, Inc. announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered into a definitive collaboration and distribution agreement for Bystolic(R)...
IT & Data Management
Desktop Medicine – New Approach To Medicine
A model defined by Jason Karlawish, MD, Associate Professor of Medicine and Medical Ethics at the University of Pennsylvania School of Medicine, involves clinicians...
IT & Data Management
Smart-Pill Technology
Novartis says it plans to submit its microchip containing ‘smart-pill’ technology to European regulators within 18 months. Novartis is currently using the technology on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
